Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Fukuda Denshi CoFKDSF 83 EV-to-EBIT is 9.15 as of Aug. 12, 2026, which is 88% above its 10-year median of 4.88. GuruFocus rates FKDSF with a GF Score™ of 83/100 and a GF Value™ of $26.44. The stock has 5 warning signs investors should review. Among 472 Medical Devices & Instruments companies, Fukuda Denshi Co ranks better than 79.66% on this metric.
Fukuda Denshi Co (OTCPK:FKDSF) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Fukuda Denshi Co's Enterprise Value for the quarter that ended in Mar. 2026 was $757.3 Mil.
Fukuda Denshi Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $177.6 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fukuda Denshi Co EV-to-EBIT Related Terms
Fukuda Denshi Co EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Fukuda Denshi Co's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Fukuda Denshi Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fukuda Denshi Co EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Fukuda Denshi Co's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Fukuda Denshi Co's EV-to-EBIT falls into.
Fukuda Denshi Co's current Enterprise Value is $1,625.6 Mil.
Fukuda Denshi Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $177.6 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fukuda Denshi Co (FKDSF) has a EV-to-EBIT of 9.15 as of Aug. 12, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Fukuda Denshi Co and its competitors. This is 88% above median its historical median of 4.88. Over the past decade, Fukuda Denshi Co's EV-to-EBIT has ranged from 1.79 to 10.19. According to the industry distribution chart, Fukuda Denshi Co ranks #96 out of 472 companies in the Medical Devices & Instruments industry, placing it in the top 20.3%.
Is Fukuda Denshi Co's EV-to-EBIT too high?
Fukuda Denshi Co's current EV-to-EBIT of 9.15 is 88% above median its 10-year median of 4.88. Over the past 10 years, this metric has ranged from a low of 1.79 to a high of 10.19. The Medical Devices & Instruments industry median EV-to-EBIT is 19.22. Fukuda Denshi Co's value of 9.15 is 52.4% below this industry median. Based on the distribution chart, Fukuda Denshi Co ranks #96 out of 472 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Fukuda Denshi Co has a GF Score™ of 83/100, reflecting its overall financial health beyond just this single metric.
How does Fukuda Denshi Co's EV-to-EBIT compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Fukuda Denshi Co ranks #96 out of 472 companies for EV-to-EBIT. This places Fukuda Denshi Co in the top 20% of its industry — outperforming the majority of peers. The industry median EV-to-EBIT is 19.22. Fukuda Denshi Co's value of 9.15 is 52.4% below this benchmark. Historically, Fukuda Denshi Co's own EV-to-EBIT has ranged from 1.79 to 10.19 over the past decade. While the company's 10-year median is 4.88 vs. the industry median of 19.22, Fukuda Denshi Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 19.22, based on 472 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fukuda Denshi Co's current EV-to-EBIT of 9.15 is 52.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Fukuda Denshi Co and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 19.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fukuda Denshi Co's current EV-to-EBIT is 9.15, which is 88% above median its own 10-year median of 4.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fukuda Denshi Co stock overvalued right now?
Fukuda Denshi Co (FKDSF) has a current EV-to-EBIT of 9.15. The stock's GF Value™ is $26.44, compared to a current price of $42.55 — trading 60.9% above its estimated fair value. The current EV-to-EBIT is 9.15, which is 88% above median its 10-year median of 4.88 and 52.4% below the Medical Devices & Instruments industry median of 19.22. Fukuda Denshi Co's overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Fukuda Denshi Co (FKDSF), the current EV-to-EBIT is 9.15 as of Aug. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fukuda Denshi Co (FKDSF) Overvalued in 2026?
Based on GuruFocus' analysis, Fukuda Denshi Co stock appears to be overvalued.
The current stock price of $42.55 is trading 60.9% above its estimated GF Value™ of $26.44.
Key valuation signals for FKDSF:
EV-to-EBIT: 9.15 (88% above median its 10-year median of 4.88)
GF Value™: $26.44 vs. price of $42.55 (60.9% above fair value)
Industry Position: 52.4% below the Medical Devices & Instruments median (#96 of 472)
No single metric tells the full story. See the FKDSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fukuda Denshi Co Ltd develops and manufactures medical electronic equipment. The firm operates in four segments: physiological diagnostic equipment, patient monitoring equipment, medical treatment equipment, and consumables and other products. The physiological diagnostic equipment business sells electrocardiographs, vascular screening systems, and blood cell counters. The patient monitoring equipment segment sells patient monitors and transmitters. The medical treatment equipment segment contributes the largest proportion of revenue and sells pacemakers and medical equipment for home treatment. The consumables and other products segment sells disposable electrodes and consumables used for the firm's devices. Fukuda Denshi generates the vast majority of its sales in Japan.
83GF Score
Get the complete analysis for FKDSF
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FKDSF has been successfully added to your 
